相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Real World Effectiveness of Benralizumab in Severe Eosinophilic Asthma (vol 159, pg 496, 2022)
[Anonymous]
CHEST (2023)
Role of Biologics in Chronic Rhinosinusitis With Nasal Polyposis: State of the Art Review
Christine Kim et al.
OTOLARYNGOLOGY-HEAD AND NECK SURGERY (2021)
Factors affecting upper airway control of NSAID-exacerbated respiratory disease: A real-world study of 167 patients
Annina Lyly et al.
IMMUNITY INFLAMMATION AND DISEASE (2021)
Real-World Effectiveness of Benralizumab in Severe Eosinophilic Asthma
Joanne E. Kavanagh et al.
CHEST (2021)
Th2 inflammatory responses in the development of nasal polyps and chronic rhinosinusitis
Gwanghui Ryu et al.
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY (2020)
New biological treatments for asthma and skin allergies
Stefanie Eyerich et al.
ALLERGY (2020)
Dual blockade of IL-4 and IL-13 with dupilumab, an IL-4Rα antibody, is required to broadly inhibit type 2 inflammation
Audrey Le Floc'h et al.
ALLERGY (2020)
Biologics in chronic rhinosinusitis with nasal polyposis
Tanya M. Laidlaw et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2020)
Staphylococcus aureus and its IgE-inducing enterotoxins in asthma: current knowledge
Claus Bachert et al.
EUROPEAN RESPIRATORY JOURNAL (2020)
Endotypes of chronic rhinosinusitis: Impact on management
Lars-Olaf Cardell et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)
Comparison of C3d immunohistochemical staining to enzyme-linked immunosorbent assay and immunofluorescence for diagnosis of bullous pemphigoid
Leo L. Wang et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2020)
Omalizumab in patients with NSAID-exacerbated respiratory disease
Ulrike Foerster-Ruhrmann et al.
RHINOLOGY (2020)
The role of biologics in chronic rhinosinusitis: a systematic review
Isma Z. Iqbal et al.
INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY (2020)
Phenotypes in Chronic Rhinosinusitis
Justin P. McCormick et al.
CURRENT ALLERGY AND ASTHMA REPORTS (2020)
Endotypes of Chronic Rhinosinusitis with Nasal Polyps: Pathology and Possible Therapeutic Implications
Claus Bachert et al.
Journal of Allergy and Clinical Immunology-In Practice (2020)
Airway Epithelial Dynamics in Allergy and Related Chronic Inflammatory Airway Diseases
Anu Laulajainen-Hongisto et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
Benralizumab strongly reduces blood basophils in severe eosinophilic asthma
Marek Lommatzsch et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2020)
High Discontinuation Rates of Peroral ASA Treatment for CRSwNP: A Real-World Multicenter Study of 171 N-ERD Patients
Anu Laulajainen-Hongisto et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2020)
Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials
Philippe Gevaert et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)
Burden and socioeconomics of asthma, allergic rhinitis, atopic dermatitis and food allergy
Boudewijn J. H. Dierick et al.
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH (2020)
Effectiveness of fevipiprant in reducing exacerbations in patients with severe asthma (LUSTER-1 and LUSTER-2): two phase 3 randomised controlled trials
Christopher E Brightling et al.
Lancet Respiratory Medicine (2020)
The Molecular Mechanisms That Underlie the Immune Biology of Anti-drug Antibody Formation Following Treatment With Monoclonal Antibodies
Anna Vaisman-Mentesh et al.
FRONTIERS IN IMMUNOLOGY (2020)
Engineered antibodies to combat viral threats
Xiaojie Yu et al.
NATURE (2020)
Response to mepolizumab treatment is sustained across 4-weekly dosing periods
Ian D. Pavord et al.
ERJ OPEN RESEARCH (2020)
Evolution of our view on the IgE molecule role in bronchial asthma and the clinical effect of its modulation by omalizumab: Where do we stand today?
Jakub Novosad et al.
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2020)
Heterogeneity in the initiation, development and function of type 2 immunity
William C. Gause et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Biologics for chronic rhinosinusitis
Lee-Yee Chong et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2020)
Diagnosis and management of NSAID-Exacerbated Respiratory Disease (N-ERD)a EAACI position paper
Marek L. Kowalski et al.
ALLERGY (2019)
Allergic conversion of protective mucosal immunity against nasal bacteria in patients with chronic rhinosinusitis with nasal polyposis
Kazuya Takeda et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2019)
Conjunctivitis in dupilumab clinical trials
B. Akinlade et al.
BRITISH JOURNAL OF DERMATOLOGY (2019)
Risk of adult-onset asthma increases with the number of allergic multimorbidities and decreases with age
Sanna Toppila-Salmi et al.
ALLERGY (2019)
Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials
Claus Bachert et al.
LANCET (2019)
Comparing biologicals and small molecule drug therapies for chronic respiratory diseases: An EAACI Taskforce on Immunopharmacology position paper
Franziska Roth-Walter et al.
ALLERGY (2019)
Targeting lipid mediators in asthma: time for reappraisal
Zuzana Diamant et al.
CURRENT OPINION IN PULMONARY MEDICINE (2019)
Serum IgG Concentrations in Adult Patients Experiencing Virus-Induced Severe Asthma Exacerbations
Morgane Verduyn et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2019)
Interleukin-5 in the Pathophysiology of Severe Asthma
Corrado Pelaia et al.
FRONTIERS IN PHYSIOLOGY (2019)
Targeting cell signaling in allergic asthma
Seyyed Shamsadin Athari
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2019)
Periostin as a marker of mucosal remodelling in chronic rhinosinusitis
J.A. Ebenezer et al.
RHINOLOGY (2018)
The effect of systemic treatments on periostin expression reflects their interference with the eosinophilic inflammation in chronic rhinosinusitis with nasal polyps
E. de Schryver et al.
RHINOLOGY (2018)
Healthcare resource use and costs of severe, uncontrolled eosinophilic asthma in the UK general population
Marjan Kerkhof et al.
THORAX (2018)
The asthma-rhinitis multimorbidity is associated with IgE polysensitization in adolescents and adults
V. Siroux et al.
ALLERGY (2018)
Staphylococcus aureus Induces a Mucosal Type 2 Immune Response via Epithelial Cell-derived Cytokines
Feng Lan et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2018)
Omalizumab effectiveness in patients with severe allergic asthma according to blood eosinophil count: the STELLAIR study
Marc Humbert et al.
EUROPEAN RESPIRATORY JOURNAL (2018)
Staphylococcus aureus controls interleukin-5 release in upper airway inflammation
C. Bachert et al.
JOURNAL OF PROTEOMICS (2018)
Efficacy and Safety of Dupilumab in Glucocorticoid-Dependent Severe Asthma
Klaus F. Rabe et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Selecting the right biologic for your patients with severe asthma
Laurie A. Manka et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2018)
The Genetics and Genomics of Asthma
Saffron A. G. Willis-Owen et al.
ANNUAL REVIEW OF GENOMICS AND HUMAN GENETICS, VOL 19 (2018)
Aspirin-Exacerbated Respiratory Disease
Andrew A. White et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Looking for Airways Periostin in Severe Asthma Could It Be Useful for Clustering Type 2 Endotype?
Giovanna E. Carpagnano et al.
CHEST (2018)
An introduction to immunology and immunopathology
Jean S. Marshall et al.
ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY (2018)
Omalizumab, the first available antibody for biological treatment of severe asthma: more than a decade of real-life effectiveness
Corrado Pelaia et al.
THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE (2018)
Nordic consensus statement on the systematic assessment and management of possible severe asthma in adults
Celeste Porsbjerg et al.
EUROPEAN CLINICAL RESPIRATORY JOURNAL (2018)
Different roles of Staphylococcus aureus enterotoxin in different subtypes of nasal polyps
Ke-Jia Cheng et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2017)
Care pathways for the selection of a biologic in severe asthma
Jean Bousquet et al.
EUROPEAN RESPIRATORY JOURNAL (2017)
Fevipiprant, an oral prostaglandin DP2 receptor (CRTh2) antagonist, in allergic asthma uncontrolled on low-dose inhaled corticosteroids
Eric D. Bateman et al.
EUROPEAN RESPIRATORY JOURNAL (2017)
Diagnosis and Management of Asthma in Adults A Review
Jennifer L. McCracken et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Staphylococcal serine protease-like proteins are pacemakers of allergic airway reactions to Staphylococcus aureus
Sebastian Stentzel et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)
Reduced need for surgery in severe nasal polyposis with mepolizumab: Randomized trial
Claus Bachert et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)
Tezepelumab in Adults with Uncontrolled Asthma
Jonathan Corren et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Dupilumab in the management of moderate-to-severe asthma: the data so far
Pilar Barranco et al.
THERAPEUTICS AND CLINICAL RISK MANAGEMENT (2017)
Endotype-driven treatment in chronic upper airway diseases
Glynnis De Greve et al.
CLINICAL AND TRANSLATIONAL ALLERGY (2017)
The Role of Periostin in the Occurrence and Progression of Eosinophilic Chronic Sinusitis with Nasal Polyps
Ming Xu et al.
SCIENTIFIC REPORTS (2017)
Asthma biomarkers in the age of biologics
Harold Kim et al.
ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY (2017)
Cellular and molecular mechanisms of asthma and COPD
Peter J. Barnes
CLINICAL SCIENCE (2017)
Efficacy and safety of setipiprant in seasonal allergic rhinitis: results from Phase 2 and Phase 3 randomized, double-blind, placebo- and active-referenced studies
Paul Ratner et al.
ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY (2017)
Development of a new ARCHITECT automated periostin immunoassay
Nicolette M. Jeanblanc et al.
CLINICA CHIMICA ACTA (2017)
Revisiting Type 2-high and Type 2-low airway inflammation in asthma: current knowledge and therapeutic implications
D. Robinson et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2017)
Targeting key proximal drivers of type 2 inflammation in disease
Namita A. Gandhi et al.
NATURE REVIEWS DRUG DISCOVERY (2016)
The discovery of IgE 50 years later
Thomas A. E. Platts-Mills et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2016)
Reslizumab for Inadequately Controlled Asthma With Elevated Blood Eosinophil Levels A Randomized Phase 3 Study
Leif Bjermer et al.
CHEST (2016)
Mepolizumab in the treatment of severe eosinophilic asthma
Valentina Fainardi et al.
IMMUNOTHERAPY (2016)
Inflammatory endotypes of chronic rhinosinusitis based on cluster analysis of biomarkers
Peter Tomassen et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)
Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial
Eugene R. Bleecker et al.
LANCET (2016)
The oral CRTh2 antagonist QAW039 (fevipiprant): A phase II study in uncontrolled allergic asthma
Veit J. Erpenbeck et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2016)
Efficacy and safety of a CXCR2 antagonist, AZD5069, in patients with uncontrolled persistent asthma: a randomised, double-blind, placebo-controlled trial
Paul M. O'Byrne et al.
LANCET RESPIRATORY MEDICINE (2016)
Specific Induction of TSLP by the Viral RNA Analogue Poly(I:C) in Primary Epithelial Cells Derived from Nasal Polyps
Korneliusz Golebski et al.
PLOS ONE (2016)
Use of Metatranscriptomics in Microbiome Research
Stavros Bashiardes et al.
BIOINFORMATICS AND BIOLOGY INSIGHTS (2016)
Treatment with anti-OX40L or anti-TSLP does not alter the frequency of T regulatory cells in allergic asthmatics
A. J. Baatjes et al.
ALLERGY (2015)
EAACI IG Biologicals task force paper on the use of biologic agents in allergic disorders
O. Boyman et al.
ALLERGY (2015)
Therapeutic implications of 'neutrophilic asthma'
Parameswaran Nair et al.
CURRENT OPINION IN PULMONARY MEDICINE (2015)
Strategies targeting the IL-4/IL-13 axes in disease
Richard D. May et al.
CYTOKINE (2015)
An overview of FDA-approved biologics medicines
Michael S. Kinch
DRUG DISCOVERY TODAY (2015)
Association of periostin expression with eosinophilic inflammation in nasal polyps
Min Wang et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2015)
Respiratory epithelial cells orchestrate pulmonary innate immunity
Jeffrey A. Whitsett et al.
NATURE IMMUNOLOGY (2015)
Allergic multimorbidity of asthma, rhinitis and eczema over 20years in the German birth cohort MAS
Hannah Gough et al.
PEDIATRIC ALLERGY AND IMMUNOLOGY (2015)
Efficacy of BI 671800, an oral CRTH2 antagonist, in poorly controlled asthma as sole controller and in the presence of inhaled corticosteroid treatment
Ian P. Hall et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2015)
Antiviral Monoclonal Antibodies: Can They Be More Than Simple Neutralizing Agents?
Mireia Pelegrin et al.
TRENDS IN MICROBIOLOGY (2015)
Asthma risk factors
Elina Toskala et al.
INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY (2015)
Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials
Mario Castro et al.
LANCET RESPIRATORY MEDICINE (2015)
Molecular Mechanisms of Nasal Epithelium in Rhinitis and Rhinosinusitis
Sanna Toppila-Salmi et al.
CURRENT ALLERGY AND ASTHMA REPORTS (2015)
Natural Antibodies Bridge Innate and Adaptive Immunity
Saswati Panda et al.
JOURNAL OF IMMUNOLOGY (2015)
Type 2 inflammation in asthma - present in most, absent in many
John V. Fahy
NATURE REVIEWS IMMUNOLOGY (2015)
Setipiprant, a selective CRTH2 antagonist, reduces allergen-induced airway responses in allergic asthmatics
Z. Diamant et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2014)
Cytokine Profiles in Allergic Rhinitis
Guy Scadding
CURRENT ALLERGY AND ASTHMA REPORTS (2014)
International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma
Kian Fan Chung et al.
EUROPEAN RESPIRATORY JOURNAL (2014)
Effects of an Anti-TSLP Antibody on Allergen-Induced Asthmatic Responses
Gail M. Gauvreau et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
A Anti-TNF inhibits the Airways neutrophilic inflammation induced by inhaled endotoxin in human
Olivier Michel et al.
BMC PHARMACOLOGY & TOXICOLOGY (2014)
Omalizumab for asthma in adults and children
Rebecca Normansell et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2014)
Staphylococcus aureus enterotoxin-specific IgE is associated with asthma in the general population: a GA2LEN study
P. Tomassen et al.
ALLERGY (2013)
Excessive Fibrin Deposition in Nasal Polyps Caused by Fibrinolytic Impairment through Reduction of Tissue Plasminogen Activator Expression
Tetsuji Takabayashi et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)
Randomized, Double-Blind, Placebo-controlled Study of Brodalumab, a Human Anti-IL-17 Receptor Monoclonal Antibody, in Moderate to Severe Asthma
William W. Busse et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)
Antibody deficiency in chronic rhinosinusitis: Epidemiology and burden of illness
Christopher J. Ocampo et al.
AMERICAN JOURNAL OF RHINOLOGY & ALLERGY (2013)
Nonallergic rhinitis
Russell A. Settipane et al.
AMERICAN JOURNAL OF RHINOLOGY & ALLERGY (2013)
Aspirin-Intolerant Asthma: A Comprehensive Review of Biomarkers and Pathophysiology
Juan R. Velazquez et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2013)
Inhibition of the asthmatic allergen challenge response by the CRTH2 antagonist OC000459
Dave Singh et al.
EUROPEAN RESPIRATORY JOURNAL (2013)
Safety and efficacy of the prostaglandin D2 receptor antagonist AMG 853 in asthmatic patients
William W. Busse et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
Omalizumab is effective in allergic and nonallergic patients with nasal polyps and asthma
Philippe Gevaert et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
TH2, allergy and group 2 innate lymphoid cells
Paula Licona-Limon et al.
NATURE IMMUNOLOGY (2013)
Targeting eosinophils in allergy, inflammation and beyond
Patricia C. Fulkerson et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
Dupilumab in Persistent Asthma with Elevated Eosinophil Levels
Sally Wenzel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Low prostaglandin E-2 and cyclooxygenase expression in nasal mucosa fibroblasts of aspirin-intolerant asthmatics
Jordi Roca-Ferrer et al.
RESPIROLOGY (2013)
Asthma in adults and its association with chronic rhinosinusitis: The GA2LEN survey in Europe
D. Jarvis et al.
ALLERGY (2012)
Acquired cilia dysfunction in chronic rhinosinusitis
David Gudis et al.
AMERICAN JOURNAL OF RHINOLOGY & ALLERGY (2012)
A randomized, double-blind, placebo-controlled study of the CRTH2 antagonist OC000459 in moderate persistent asthma
N. Barnes et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2012)
Safety and efficacy of a CXCR2 antagonist in patients with severe asthma and sputum neutrophils: a randomized, placebo-controlled clinical trial
P. Nair et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2012)
Benralizumab - a humanized mAb to IL-5Rα with enhanced antibody-dependent cell-mediated cytotoxicity - a novel approach for the treatment of asthma
Aasia Ghazi et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2012)
EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists
Wytske J. Fokkens et al.
RHINOLOGY (2012)
Chronic rhinosinusitis in Europe - an underestimated disease. A GA2LEN study
D. Hastan et al.
ALLERGY (2011)
The association between bacterial colonization and inflammatory pattern in Chinese chronic rhinosinusitis patients with nasal polyps
L. Ba et al.
ALLERGY (2011)
Prostaglandins and Inflammation
Emanuela Ricciotti et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
Mepolizumab, a humanized anti-IL-5 mAb, as a treatment option for severe nasal polyposis
Philippe Gevaert et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)
Human IL-25-and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161
Jenny M. Mjosberg et al.
NATURE IMMUNOLOGY (2011)
Monoclonal antibodies for the treatment of asthma
Matthew C. Catley et al.
PHARMACOLOGY & THERAPEUTICS (2011)
MEDI-563, a humanized anti-IL-5 receptor α mAb with enhanced antibody-dependent cell-mediated cytotoxicity function
Roland Kolbeck et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
Presence of IL-5 protein and IgE antibodies to staphylococcal enterotoxins in nasal polyps is associated with comorbid asthma
Claus Bachert et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
A randomized, double-blind, placebo-controlled trial of anti-IgE for chronic rhinosinusitis
J. M. Pinto et al.
RHINOLOGY (2010)
Intrinsic asthma: not so different from allergic asthma but driven by superantigens?
P. J. Barnes
CLINICAL AND EXPERIMENTAL ALLERGY (2009)
Analytical validation of a highly sensitive microparticle-based immunoassay for the quantitation of IL-13 in human serum using the Erenna® immunoassay system
Katie St Ledger et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2009)
Molecular and structural basis of cytokine receptor pleiotropy in the interleukin-4/13 system
Sherry L. LaPorte et al.
CELL (2008)
Anti-TNF-α therapies in chronic obstructive pulmonary diseases
Sabina A. Antoniu et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2008)
Eosinophil trafficking in allergy and asthma
Helene F. Rosenberg et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2007)
Triggers of IgE class switching and allergy development
Lars K. Poulsen et al.
ANNALS OF MEDICINE (2007)
Nasal IL-5 levels determine the response to anti-IL-5 treatment in patients with nasal polyps
Philippe Gevaert et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2006)
Clinical and pathologic perspectives on aspirin sensitivity and asthma
Donald D. Stevenson et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2006)
Anti-TNF-α and Th1 cytokine-directed therapies for the treatment of asthma
M Cazzola et al.
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY (2006)
Aspirin sensitivity and severity of asthma: Evidence for irreversible airway obstruction in patients with severe or difficult-to-treat asthma
K Mascia et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2005)
Omalizumab-induced reductions in mast cell FcεRI expression and function
LA Beck et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2004)
The regulation of immunoglobulin E class-switch recombination
RS Geha et al.
NATURE REVIEWS IMMUNOLOGY (2003)
Prevalence of nasal polyps in adults:: The Skovde population-based study
L Johansson et al.
ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY (2003)
Anti-interleukin-9 antibody treatment inhibits airway inflammation and hyperreactivity in mouse asthma model
G Cheng et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2002)
The estimated incidence of symptomatic nasal polyps
K Larsen et al.
ACTA OTO-LARYNGOLOGICA (2002)
分享论文
